SENTINELONE INC -CLASS A (1SUS.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1SUS • US81730H1095

12.55 EUR
-0.45 (-3.46%)
Last: Jan 14, 2026, 07:00 PM
Fundamental Rating

4

1SUS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 115 industry peers in the Software industry. 1SUS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 1SUS shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year 1SUS was profitable.
  • In the past year 1SUS had a positive cash flow from operations.
  • In the past 5 years 1SUS always reported negative net income.
  • In the past 5 years 1SUS reported 4 times negative operating cash flow.
1SUS.MI Yearly Net Income VS EBIT VS OCF VS FCF1SUS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • 1SUS's Return On Assets of -16.91% is on the low side compared to the rest of the industry. 1SUS is outperformed by 83.19% of its industry peers.
  • 1SUS's Return On Equity of -26.54% is on the low side compared to the rest of the industry. 1SUS is outperformed by 79.83% of its industry peers.
Industry RankSector Rank
ROA -16.91%
ROE -26.54%
ROIC N/A
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
1SUS.MI Yearly ROA, ROE, ROIC1SUS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100 200 300

1.3 Margins

  • With a Gross Margin value of 74.69%, 1SUS perfoms like the industry average, outperforming 52.94% of the companies in the same industry.
  • 1SUS's Gross Margin has improved in the last couple of years.
  • 1SUS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
1SUS.MI Yearly Profit, Operating, Gross Margins1SUS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • 1SUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, 1SUS has more shares outstanding
  • Compared to 5 years ago, 1SUS has more shares outstanding
  • 1SUS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1SUS.MI Yearly Shares Outstanding1SUS.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M
1SUS.MI Yearly Total Debt VS Total Assets1SUS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 2.36 indicates that 1SUS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • 1SUS has a Altman-Z score (2.36) which is comparable to the rest of the industry.
  • There is no outstanding debt for 1SUS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.36
ROIC/WACCN/A
WACC11.1%
1SUS.MI Yearly LT Debt VS Equity VS FCF1SUS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • 1SUS has a Current Ratio of 1.52. This is a normal value and indicates that 1SUS is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.52, 1SUS is in line with its industry, outperforming 54.62% of the companies in the same industry.
  • A Quick Ratio of 1.52 indicates that 1SUS should not have too much problems paying its short term obligations.
  • The Quick ratio of 1SUS (1.52) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.52
1SUS.MI Yearly Current Assets VS Current Liabilites1SUS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 1800.00% over the past year.
  • The Revenue has grown by 24.09% in the past year. This is a very strong growth!
  • The Revenue has been growing by 77.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1800%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.7%
Revenue 1Y (TTM)24.09%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%22.91%

3.2 Future

  • The Earnings Per Share is expected to grow by 75.02% on average over the next years. This is a very strong growth
  • 1SUS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.85% yearly.
EPS Next Y289.07%
EPS Next 2Y148.24%
EPS Next 3Y106.38%
EPS Next 5Y75.02%
Revenue Next Year22.54%
Revenue Next 2Y21.29%
Revenue Next 3Y19.9%
Revenue Next 5Y20.85%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1SUS.MI Yearly Revenue VS Estimates1SUS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 1B 2B 3B
1SUS.MI Yearly EPS VS Estimates1SUS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • 1SUS is valuated quite expensively with a Price/Earnings ratio of 89.64.
  • The rest of the industry has a similar Price/Earnings ratio as 1SUS.
  • The average S&P500 Price/Earnings ratio is at 27.92. 1SUS is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 47.83, the valuation of 1SUS can be described as expensive.
  • 1SUS's Price/Forward Earnings is on the same level as the industry average.
  • 1SUS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.78.
Industry RankSector Rank
PE 89.64
Fwd PE 47.83
1SUS.MI Price Earnings VS Forward Price Earnings1SUS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • The rest of the industry has a similar Price/Free Cash Flow ratio as 1SUS.
Industry RankSector Rank
P/FCF 109.42
EV/EBITDA N/A
1SUS.MI Per share data1SUS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • 1SUS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1SUS's earnings are expected to grow with 106.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y148.24%
EPS Next 3Y106.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for 1SUS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SENTINELONE INC -CLASS A

BIT:1SUS (1/14/2026, 7:00:00 PM)

12.55

-0.45 (-3.46%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-04
Earnings (Next)03-10
Inst Owners74.23%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner ChangeN/A
Market Cap4.21B
Revenue(TTM)955.65M
Net Income(TTM)-411.29M
Analysts78.18
Price Target18.72 (49.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.2%
Min EPS beat(2)29.34%
Max EPS beat(2)37.07%
EPS beat(4)4
Avg EPS beat(4)66.06%
Min EPS beat(4)23.01%
Max EPS beat(4)174.81%
EPS beat(8)7
Avg EPS beat(8)80.73%
EPS beat(12)11
Avg EPS beat(12)65.4%
EPS beat(16)15
Avg EPS beat(16)53.64%
Revenue beat(2)0
Avg Revenue beat(2)-1.73%
Min Revenue beat(2)-1.95%
Max Revenue beat(2)-1.5%
Revenue beat(4)0
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-1.95%
Max Revenue beat(4)-0.52%
Revenue beat(8)2
Avg Revenue beat(8)-0.85%
Revenue beat(12)4
Avg Revenue beat(12)-0.41%
Revenue beat(16)8
Avg Revenue beat(16)0.68%
PT rev (1m)-11.62%
PT rev (3m)N/A
EPS NQ rev (1m)-18.79%
EPS NQ rev (3m)-18.71%
EPS NY rev (1m)2.48%
EPS NY rev (3m)2.57%
Revenue NQ rev (1m)-0.7%
Revenue NQ rev (3m)-0.7%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE 89.64
Fwd PE 47.83
P/S 5.17
P/FCF 109.42
P/OCF 71.74
P/B 3.19
P/tB 9.92
EV/EBITDA N/A
EPS(TTM)0.14
EY1.12%
EPS(NY)0.26
Fwd EY2.09%
FCF(TTM)0.11
FCFY0.91%
OCF(TTM)0.17
OCFY1.39%
SpS2.43
BVpS3.94
TBVpS1.26
PEG (NY)0.31
PEG (5Y)N/A
Graham Number3.52
Profitability
Industry RankSector Rank
ROA -16.91%
ROE -26.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.69%
FCFM 4.72%
ROA(3y)-14.45%
ROA(5y)-15.84%
ROE(3y)-20.46%
ROE(5y)-23.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.32%
GM growth 5Y4.22%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 48.39%
Cap/Sales 2.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 1.52
Altman-Z 2.36
F-Score6
WACC11.1%
ROIC/WACCN/A
Cap/Depr(3y)58.32%
Cap/Depr(5y)105.17%
Cap/Sales(3y)3.59%
Cap/Sales(5y)4.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1800%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.7%
EPS Next Y289.07%
EPS Next 2Y148.24%
EPS Next 3Y106.38%
EPS Next 5Y75.02%
Revenue 1Y (TTM)24.09%
Revenue growth 3Y58.89%
Revenue growth 5Y77.59%
Sales Q2Q%22.91%
Revenue Next Year22.54%
Revenue Next 2Y21.29%
Revenue Next 3Y19.9%
Revenue Next 5Y20.85%
EBIT growth 1Y5.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year336.9%
EBIT Next 3Y92.12%
EBIT Next 5YN/A
FCF growth 1Y144.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y181.7%
OCF growth 3YN/A
OCF growth 5YN/A

SENTINELONE INC -CLASS A / 1SUS.MI FAQ

Can you provide the ChartMill fundamental rating for SENTINELONE INC -CLASS A?

ChartMill assigns a fundamental rating of 4 / 10 to 1SUS.MI.


Can you provide the valuation status for SENTINELONE INC -CLASS A?

ChartMill assigns a valuation rating of 3 / 10 to SENTINELONE INC -CLASS A (1SUS.MI). This can be considered as Overvalued.


How profitable is SENTINELONE INC -CLASS A (1SUS.MI) stock?

SENTINELONE INC -CLASS A (1SUS.MI) has a profitability rating of 1 / 10.


What is the valuation of SENTINELONE INC -CLASS A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SENTINELONE INC -CLASS A (1SUS.MI) is 89.64 and the Price/Book (PB) ratio is 3.19.